FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

27979911000001107: Dretine 0.03mg/3mg tablets (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Dec 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
88036701000001111 Dretine 0.03mg/3mg tablets (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111565101000001117 Dretine 0.03mg/3mg tablets (Theramex HQ UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Is a Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has active ingredient Drospirenone false Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Is a Dretine true Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dretine 0.03mg/3mg tablets (Teva UK Ltd) 63 tablet 3 x 21 tablets Has AMP True Dretine 0.03mg/3mg tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start